=== SUMMARY ===
- The post argues Corsair (CRSR) is deeply undervalued at ~$8.81, with a price target of $45 driven by its new AI Workstation 300 product, record gross margins, and improving financials.
- The author contends the market still prices CRSR as a peripherals company (0.59x sales) rather than an emerging AI hardware player, and expects a multiple re-rate to 2.5-3x sales.
- Quality assessment: Well-researched DD with specific product details, financial data (Q1 beat, EBITDA guidance), and valuation comparisons, though it acknowledges risks (EagleTree, AMD execution) and is slightly late given the post-pump price action.
=== SENTIMENT ===
BULLISH
=== TRADE IDEAS ===
CRSR - LONG | confidence: 0.75 | sentiment: +0.70
Speaker: u/Interesting_Dingo194
Thesis:
1. THE FACT: Corsair’s AI Workstation 300 (AMD Ryzen AI MAX+ 395, 96GB unified VRAM) targets the local AI market, which is growing. Q1 beat consensus, record gross margins, EBITDA raised to $110M, net income positive.
2. THE BRIDGE: The stock trades at 0.59x trailing sales while “AI” peers command 8-12x. A modest re-rate to 2.5-3x sales implies a $45 price target without heroic revenue assumptions. Analysts (Barclays $11) have not updated the narrative.
3. THE VERDICT: Long CRSR as a value play with an AI catalyst. The thesis is credible but execution risk exists; entry near $11 after a 30% gap-up reduces margin of safety.
4. RISKS: EagleTree overhang, AMD chip availability/execution, macro slowdown, component shortages, potential misjudgment of AI demand.
Timeframe: medium-term
Key Points:
- AI Workstation 300 opens new revenue stream
- 0.6x sales vs peers >2x is mispricing
- Record margins & positive net income support
- PT $45 requires no heroic revenue
- Entry after 30% pump weakens risk/reward
=== COMMENTS SUMMARY ===
Community reactions highlight the stock’s 31% aftermarket surge to ~$11, with some users lamenting they missed the move and others cautioning that buying after a 100% pump is risky. Th
Оценка52
Комментарии76
% апвоутов78%
▶ Полный текст поста
Stock’s at $8.81. I think it goes to $45. Here’s why.
Corsair just released a machine called the AI Workstation 300. AMD Ryzen AI MAX+ 395, 96 gigabytes of unified VRAM, 128 gigs of RAM, 4 terabytes of NVMe, fits in a 4.4 litre case, costs $4,200. That’s the product. Write it down.
Every small dev shop, every indie studio, every law firm that wants to run a local LLM without sending client data to a server farm in Virginia — this is their computer now. The whole “local AI” thing isn’t a niche anymore. People are actually doing it. Corsair built the right box at the right time and priced it where a purchasing manager can approve it without a meeting.
The financials are quietly becoming a real story. Q1 beat consensus. Record gross margins. EBITDA guidance revised up to $110 million for the year. Net income is positive. This is not a company that’s bleeding out — it’s a company that’s been boring for three years and is about to become interesting.
The valuation is the part that genuinely puzzles me. 0.59x trailing sales. $863 million market cap on $1.46 billion in revenue. Any company with “AI” in the product name that trades on vibes goes for 8 to 12 times sales. Corsair is getting valued like a company that sells mousepads. They sell mousepads AND they just entered the local AI infrastructure market. The market hasn’t updated yet.
The re-rate is simple. Revenue mix shifts toward AI hardware. Analysts stop modeling this as a peripheral company. Multiple expands from 0.6x to something resembling an AI hardware peer — call it 2.5 to 3x — and you’re at $45 without needing heroic revenue assumptions.
Barclays has an $11 target and rates it overweight. That’s the bull on Wall Street right now. Eleven dollars. I’m saying $45. One of us is wrong and I’m aware it might be me.
Risks: EagleTree overhang, AMD execution, macro, components, I could just be wrong about all of this.
Not financial advice. I work at the Fed.
Corsair’s AI Workstation 300 (AMD Ryzen AI MAX+ 395, 96GB unified VRAM) targets the local AI market, which is growing. Q1 beat consensus, record gross margins, EBITDA raised to $110M, net income positive. The stock trades at 0.59x trailing sales while “AI” peers command 8-12x. A modest re-rate to 2.5-3x sales implies a $45 price target without heroic revenue assumptions. Analysts (Barclays $11) have not updated the narrative. Long CRSR as a value play with an AI catalyst. The thesis is credible but execution risk exists; entry near $11 after a 30% gap-up reduces margin of safety. EagleTree overhang, AMD chip availability/execution, macro slowdown, component shortages, potential misjudgment of AI demand.
This Reddit post, published May 28, 2026,
features u/Interesting_Dingo194
discussing CRSR.
1 trade idea extracted by AI with direction and confidence scoring.